James Arthur Bristol

Insider Reports History

Entity
Individual
Location
C/O Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham, MA
Signature
/s/ Ebun S. Garner, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Arthur Bristol:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Deciphera Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 $0 $10.58 Jun 11, 2024 By Bristol Survivor's Trust
Eterna Therapeutics Inc. Director Stock Option (Right to buy) 125K Apr 26, 2024 Direct
Erasca, Inc. Director Stock Option (right to buy) 60K Jun 20, 2024 Direct

Insider Reports Filed by James Arthur Bristol

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ERAS Erasca, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
NA Deciphera Pharmaceuticals, Inc. Jun 11, 2024 6 $0 4 Jun 11, 2024 Director
ERNA Eterna Therapeutics Inc. Apr 26, 2024 1 $0 4 Apr 29, 2024 Director
ERAS Erasca, Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director
ERNA Eterna Therapeutics Inc. Oct 30, 2023 0 $0 3 Nov 13, 2023 Director
ERAS Erasca, Inc. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
DCPH Deciphera Pharmaceuticals, Inc. Jun 21, 2023 1 $0 4 Jun 23, 2023 Director
ERAS Erasca, Inc. Dec 21, 2022 1 $82.8K 4 Dec 22, 2022 Director
DCPH Deciphera Pharmaceuticals, Inc. Jun 23, 2022 1 $0 4 Jun 24, 2022 Director
ERAS Erasca, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
DCPH Deciphera Pharmaceuticals, Inc. Jan 18, 2022 1 $50K 4 Jan 20, 2022 Director
ERAS Erasca, Inc. Jul 15, 2021 0 $0 3 Jul 15, 2021 Director
DCPH Deciphera Pharmaceuticals, Inc. Jun 23, 2021 1 $0 4 Jun 25, 2021 Director